3ZLOTNIK A, YOSHIE O. Chemokines: a new classification system and their role in immunity [ J ] . Immunity, 2000, 12(2): 121-127.
4ZLOTNIK A, YOSHIE O. The chemokine super'family revisited [ J ]. Immunity, 2012, 36(5): 705-716.
5FENG L Y, OU Z L, WU F Y, et al. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival [ J ] . Clin Cancer Res, 2009, 15(9): 2962-2970.
6TURNER M D, NEDJAI B, HURST T, et al. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease [ J ] . Biochim Biophys Acta, 2014, 1843(11): 2563-2582.
7BAGGIOLINI M. Chemokines and leukocyte traffic [ J ] Nature, 1998, 392(6676): 565-568.
8ANG C R, HSIEH S L, HO F M, et al. Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF- kappa B-dependent up-regulation of intercellular adhesion molecule-l, VCAM-1, and IL-8 expression [J] . J Immunol, 2005, 174(3): 1647-1656.
9LEE W Y, WANG C J, LINT Y, et al. CXCL17, an orphan ehemokine, acts as a novel angiogenic and anti-inflammatory factor [ J ] . Am J Physiol Endocrinol Metab, 2013, 304(1): E32-E40.
10SCHRODER K, HERTZOG P J, RAVASI T, et al. Interferon- gamma: an overview of signals, mechanisms and functions [ J ] . J Leukoc Biol, 2004, 75(2): 163-189.
